Current Evidence on Abuse and Misuse of Gabapentinoids
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Link
https://link.springer.com/content/pdf/10.1007/s40264-020-00985-6.pdf
Reference115 articles.
1. Calandre EP, Rico-Villademoros F, Slim M. Alpha2delta ligands, gabapentin, pregabalin and mirogabalin: a review of their clinical pharmacology and therapeutic use. Expert Rev Neurother. 2016;16:1263–77.
2. Deeks ED. Mirogabalin: first global approval. Drugs. 2019;79(4):463–8. https://doi.org/10.1007/s40265-019-01070-8.
3. Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010;49:661–9.
4. Rogawski MA, Bazil CW. New molecular targets for antiepileptic drugs: α2δ, SV2A, and Kv7/KCNQ/M potassium channels. Curr Neurol Neurosci Rep. 2008;8(4):345–52.
5. Peng XQ, Li X, Li J, Ramachandran PV, Gagare PD, Pratihar D, et al. Effects of gabapentin on cocaine self-administration, cocaine-triggered relapse and cocaine-enhanced nucleus accumbens dopamine in rats. Drug Alcohol Depend. 2008;97(3):207–15.
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Silencing the Phantom - Pregabalin Misuse in Amputation Patients: A Case Report;Bağımlılık Dergisi;2024-12-30
2. Prevalence and clinical outcomes of off‐label gabapentin prescription in neuropathic orofacial pain;Oral Surgery;2024-08-27
3. Assessing suicide risk in chronic pain management: a narrative review across drug classes;Expert Opinion on Drug Safety;2024-08-19
4. A review of the addictive potential of pregabalin and gabapentin;Adverse Drug Reaction Bulletin;2024-08
5. Use and misuse of psychoactive medicines: a descriptive cross-sectional study in a densely populated region of Portugal;Journal of Pharmaceutical Policy and Practice;2024-07-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3